共 50 条
- [1] SF3B1 MUTATIONS IN MDS-RS ARISE IN MULTIPOTENT HEMOPOETIC STEM CELLSHAEMATOLOGICA, 2016, 101 : 159 - 159Mortera-Blanco, T.Dimitriou, M.Woll, P. S.Elvarsdottir, E.Karimi, M.Conte, S.Jansson, M.Douagi, I.Papaemmanuil, E.Jacobsen, S. E.Hellstrom-Lindberg, E.
- [2] Long-Term Clonal Inversion in an MDS-RS Case with Dual SF3B1 MutationsBLOOD, 2022, 140 : 6898 - 6899Moura, Pedro LuisHofman, Isabel Juliana F.Nannya, YasuhitoAliouat, AffafMortera-Blanco, TeresaYoshizato, TetsuichiSaiki, RyunosukeNakagawa, Masahiro MarshallBjorklund, Ann-CharlotteWalldin, GunillaBarbosa, IndiraJansson, MonikaGrasso, FrancescaCreignou, MariaElvarsdottir, Edda MariaWoll, Petter S.Jacobsen, Sten Eirik WaelgaardOgawa, SeishiHellstrom-Lindberg, Eva
- [3] Integrative Analysis of Primary SF3B1 mt Ring Sideroblasts Provides Fundamental Insights into MDS-RS Pathogenesis and DyserythropoiesisBLOOD, 2021, 138Moura, Pedro LuisMortera-Blanco, TeresaHofman, Isabel Juliana F.Todisco, GabrieleKretzschmar, Warren W.Barbosa, IndiraBjorklund, Ann-CharlotteWalldin, GunillaJansson, MonikaYoshizato, TetsuichiWoll, Petter S.Jacobsen, Sten Erik WaelgaardLindberg, Eva Hellstrom
- [4] Somatic mutations in SF3B1 aberrant-negative MDS-RS most commonly involved in TP53 genesJOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (12) : 3586 - 3589Li, XiaoXu, FengWu, Ling-YunGuo, JuanHe, QiZhang, Zheng
- [5] SF3B1: the lord of the rings in MDSBLOOD, 2020, 136 (02) : 149 - 151Palomo, LauraSole, Rings Francesc
- [6] TARGETING THE DEFECTIVE COA PATHWAY TO IMPROVE ERYTHROPOIESIS IN SF3B1-MUTANT MDS-RS PATIENTSLEUKEMIA RESEARCH, 2023, 128Philippe, C.Mian, S.Maniati, E.Protopapa, P.Bergot, T.Piganeau, M.Nemkov, T.Di Bella, D.Morales, V.Finch, A.D'Alessandro, A.Bianchi, K.Wang, J.Gallipoli, P.Kordasti, S.Kubasch, A. S.Cross, M.Platzbecker, U.Wiseman, D.Bonnet, D.Bernard, D.Gribben, J.Rouault-Pierre, K.
- [7] Activation of Autophagy in Models of SF3B1 Mutant MDSBLOOD, 2017, 130Visconte, ValeriaAdema, VeraPrzychodzen, Bartlomiej P.Noe, AllisonToth, RachelHirbawi, YasmineHirsch, Cassandra M.Khouri, JackLeMelle, EliseBalasubramanian, Suresh K.Carraway, Hetty E.Lindner, DanielAdvani, Anjali S.Rogers, Heesun J.Phillips, James G.Radivoyevitch, TomasKelly, Kevin R.Nawrocki, Steffan T.Sekeres, Mikkael A.Maciejewski, Jaroslaw P.Carew, Jennifer
- [8] The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RSBLOOD ADVANCES, 2022, 6 (16) : 4705 - 4709Hofman, Isabel Juliana F.Mortera-Blanco, TeresaMoura, Pedro LuisVestlund, JohannaLarsson, Sigita VenckuteElvarsdottir, Edda M.Walldin, GunillaTobiasson, MagnusSander, BirgittaDimitriou, MariosJacobsen, Sten-Eirik W.Woll, Petter S.Jadersten, MartinHellstrom-Lindberg, Eva
- [9] SF3B1-Mutant Myelodysplastic Syndrome with Ringed Sideroblasts (MDS-RS) at the Single-Cell LevelBLOOD, 2020, 136Kanagal-Shamanna, RashmiAdema, VeraMa, FeiyangSantoni, AndreaYang, HuiGanan-Gomez, IreneThongon, NatthakanMontalban-Bravo, GuillermoPellegrini, MatteoBueso-Ramos, Carlos E.Garcia-Manero, GuillermoColla, Simona
- [10] SF3B1 Splicing Mutation in the Context of Therapy Related MDSBLOOD, 2020, 136Volpe, Virginia OliviaAl Ali, NajlaChan, OnyeePadron, EricSallman, David A.Komrokji, Rami S.